Kwang Yu Chang

Summary

Affiliation: National Health Research Institutes
Country: Taiwan

Publications

  1. ncbi request reprint Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5 year follow-up
    Shang Yin Wu
    Division of Hematology Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng Li Road, Tainan 704, Taiwan
    BMC Cancer 14:787. 2014
  2. pmc Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance
    Kwang Yu Chang
    Institute of Clinical Medicine College of Medicine, National Cheng Kung University, 7th Floor, No 35 Xiaodong Rd, Tainan City 701, Taiwan
    J Biomed Sci 20:43. 2013
  3. pmc Tea consumption and risk of head and neck cancer
    Cheng Chih Huang
    Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    PLoS ONE 9:e96507. 2014
  4. ncbi request reprint Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo
    Kwang Yu Chang
    Institute of Clinical Medicine, Department of Cell Biology and Anatomy, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China
    Clin Cancer Res 17:7116-26. 2011
  5. pmc Allergies and risk of head and neck cancer: an original study plus meta-analysis
    Jenn Ren Hsiao
    Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    PLoS ONE 8:e55138. 2013

Collaborators

  • Jeffrey S Chang
  • Shang Yin Wu
  • Jenn Ren Hsiao
  • Ming Wei Yang
  • Yuan hua Wu
  • Chia Jui Yen
  • Sen Tien Tsai
  • Wei Ting Hsueh
  • Cheng Chih Huang
  • Tung Yiu Wong
  • Hung I Lo
  • Jehn Shyun Huang
  • Chun Yen Ou
  • Chen Lin Lin
  • Wei Ting Lee
  • Ken Chung Chen
  • Han Chien Yang
  • Ya Ling Weng
  • Yi Hui Wang
  • Forn Chia Lin
  • Jiunn Liang Wu
  • Sheen Yie Fang
  • Fang ting Wang

Detail Information

Publications5

  1. ncbi request reprint Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5 year follow-up
    Shang Yin Wu
    Division of Hematology Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng Li Road, Tainan 704, Taiwan
    BMC Cancer 14:787. 2014
    ..This study compared the long-term outcomes between LA-NPC patients treated with neoadjuvant chemotherapy followed by radiotherapy (NACT) and those treated with concurrent chemoradiotherapy (CCRT)...
  2. pmc Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance
    Kwang Yu Chang
    Institute of Clinical Medicine College of Medicine, National Cheng Kung University, 7th Floor, No 35 Xiaodong Rd, Tainan City 701, Taiwan
    J Biomed Sci 20:43. 2013
    ..Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting...
  3. pmc Tea consumption and risk of head and neck cancer
    Cheng Chih Huang
    Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    PLoS ONE 9:e96507. 2014
    ..The current study evaluated the association between tea consumption and head and neck cancer (HNC) in Taiwan, where tea is a major agricultural product and a popular beverage...
  4. ncbi request reprint Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo
    Kwang Yu Chang
    Institute of Clinical Medicine, Department of Cell Biology and Anatomy, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China
    Clin Cancer Res 17:7116-26. 2011
    ..To develop a new treatment, we investigated the effect of a novel dual PI3K/mTOR inhibitor, NVP-BGT226 (BGT226), in head and neck cancer cells...
  5. pmc Allergies and risk of head and neck cancer: an original study plus meta-analysis
    Jenn Ren Hsiao
    Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    PLoS ONE 8:e55138. 2013
    ..It is not clear whether allergies can independently influence the risk of HNC in the presence of known strong environmental risk factors, including consumption of alcohol, betel quid, and cigarette...